课题基金 / 基金详情

CHEMPREVENTION OF AZOXYMETHANE-INDUCED COLON CANCER IN

CHEMPREVENTION OF AZOXYMETHANE-INDUCED COLON CANCER IN
化学预防偶氮甲烷诱发的结肠癌
批准号：
3617828
负责人：
MICHAEL PEREIRA
金额：
$30.46万
依托单位：
ENVIRONMENTAL HEALTH RESEARCH & TESTING
依托单位国家：
美国
项目类别：
财政年份：
1992
资助国家：
美国
项目状态：
已结题
起止时间：
1992-09-30 至 1994-03-29
来源：
https://reporter.nih.gov/project-details/3617828
关键词：
azo compounds cancer prevention carcinogenesis inhibitor chemical carcinogen chemical carcinogenesis chemical related neoplasm /cancer chemoprevention colon neoplasms combination chemotherapy disease /disorder model dosage drug screening /evaluation histochemistry /cytochemistry histology isothiocyanates laboratory rat male methane neoplasm /cancer chemotherapy

项目摘要

项目成果

MICHAEL PEREIRA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The main objective of this Master Agreement is to evaluate inhibitors or potential inhibitors of any stage of carcinogenesis in whole animal models where cancer is induced. In this Master Agreement order the purpose is to identify combinations of compounds which inhibit azoxymethane induced colon cancer in male rats.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKER ASSAYS
  • 批准号：
    7543321
  • 项目类别：
  • 资助金额：
    $139.76万
  • 财政年份：
    2005
  • 负责人：
    MICHAEL PEREIRA
  • 依托单位：
    --
PRECLINICAL EVALUATION OF INTERMEDIATE ENDPOINTS AND
PRECLINICAL EVALUATION OF INTERMEDIATE ENDPOINTS
PRECLINICAL EVALUATION OF INTERMEDIATE ENDPOINTS
海外基金